Darren Mylotte (@dmylotte) 's Twitter Profile
Darren Mylotte

@dmylotte

Husband. Daddy. Interventional Cardiologist. Those are my principles. If you don't like them....I have others.

ID: 245430302

calendar_today31-01-2011 17:45:05

1,1K Tweet

2,2K Followers

925 Following

Tomoki Ochiai (@tomokiochiai) 's Twitter Profile Photo

Our paper on impact of high implantation of transcatheter aortic valve on subsequent conduction disturbances and coronary access is online JACC Journals #JACCINT jacc.org/doi/10.1016/j.… Thanks to all co-authors and great editrial Darren Mylotte

Our paper on impact of high implantation of transcatheter aortic valve on subsequent conduction disturbances and coronary access is online <a href="/JACCJournals/">JACC Journals</a> #JACCINT 
jacc.org/doi/10.1016/j.…
Thanks to all co-authors and great editrial <a href="/dmylotte/">Darren Mylotte</a>
Yohei Turi Ohno (@ohnoturi) 's Twitter Profile Photo

Thanks to all the faculties and colleagues who have submitted the cases and abstracts, we were able to prepare this year’s PCR Tokyo Valves with lots of educational and insightful sessions. Don’t miss it!! PCRonline 🫀 #PCRtokyo

GACI (@gacintervention) 's Twitter Profile Photo

C'est avec une profonde tristesse que nous vous apprenons le décès du Pr Alain Cribier, un géant de la Cardiologie interventionnelle française et mondiale. Pionnier du remplacement valvulaire aortique percutané, il a sauvé des centaines de milliers de vies. (1/2)

C'est avec une profonde tristesse que nous vous apprenons le décès du Pr Alain Cribier, un géant de la Cardiologie interventionnelle française et mondiale. Pionnier du remplacement valvulaire aortique percutané, il a sauvé des centaines de milliers de vies. (1/2)
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

The PROTEMBO C Trial demonstrated the ProtEmbo cerebral embolic protection (CEP) system's safety and effectiveness in patients undergoing transcatheter aortic valve implantation (TAVI), achieving low rates of major adverse cardiac and cerebrovascular events (4.7%) and high

The PROTEMBO C Trial demonstrated the ProtEmbo cerebral embolic protection (CEP) system's safety and effectiveness in patients undergoing transcatheter aortic valve implantation (TAVI), achieving low rates of major adverse cardiac and cerebrovascular events (4.7%) and high
Jaffar Khan (@cathelectrosurg) 's Twitter Profile Photo

Proper training starts here 🔥 For experienced TAVR and TMVR implanters and imagers wanting to master ELECTROSURGERY techniques. Hands-on beating heart models, interactive imaging pearls, and complex case reviews led by the pioneers. NYC - save the date!

Proper training starts here 🔥

For experienced TAVR and TMVR implanters and imagers wanting to master ELECTROSURGERY techniques. 

Hands-on beating heart models, interactive imaging pearls, and complex case reviews led by the pioneers.

NYC - save the date!
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

"There are limited options for suture-based vascular closure device (VCD) failure after transfemoral TAVI. Anecdotally, the plug-based MANTA VCD has been suggested as a bailout device. Bailout MANTA after suture-based VCD failure was effective and safe in this study, but operator

"There are limited options for suture-based vascular closure device (VCD) failure after transfemoral TAVI. Anecdotally, the plug-based MANTA VCD has been suggested as a bailout device. Bailout MANTA after suture-based VCD failure was effective and safe in this study, but operator
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

The new impact factor of EuroIntervention is 7.6, an increase of 1.4 compared to the previous year, ranking the journal 21st among 221 journals in the cardiovascular field.

The new impact factor of EuroIntervention is 7.6, an increase of 1.4 compared to the previous year, ranking the journal 21st among 221 journals in the cardiovascular field.
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Get ready to present your research at #PCRTokyo 2025, on 7-9 February 2025. Your chance to gain global recognition, influence patient care, and win awards. Submit your abstracts, clinical cases and late-breaking trials by 6 October to make a difference! Submit now:

Get ready to present your research at #PCRTokyo 2025, on 7-9 February 2025. Your chance to gain global recognition, influence patient care, and win awards. Submit your abstracts, clinical cases and late-breaking trials by 6 October to make a difference! Submit now:
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

🆕 State of the Art DURABILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION TAVI shows promising long-term results, comparable to SAVR, even in younger, low-risk patients. Philippe Pibarot #Cardiology #EAPCI #TAVI #SAVR ow.ly/LCJn50SBTow

🆕 State of the Art
DURABILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION
 TAVI shows promising long-term results, comparable to SAVR, even in younger, low-risk patients. <a href="/PPibarot/">Philippe Pibarot</a>  #Cardiology #EAPCI #TAVI #SAVR
ow.ly/LCJn50SBTow
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

⚠️ Deadline alert for #PCRTokyo! Submissions close on 6 October, send in your Scientific Abstracts, Clinical Cases and Late-Breaking Trials now. Let your work get the visibility it deserves: pcronline.com/Courses/PCR-To… #interventionalcardiology Darren Mylotte Yohei Turi Ohno Didier Tchetche

⚠️ Deadline alert for #PCRTokyo! Submissions close on 6 October, send in your Scientific Abstracts, Clinical Cases and Late-Breaking Trials now. Let your work get the visibility it deserves: pcronline.com/Courses/PCR-To…

#interventionalcardiology <a href="/dmylotte/">Darren Mylotte</a> <a href="/OhnoTuri/">Yohei Turi Ohno</a> <a href="/didier_tchetche/">Didier Tchetche</a>
PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

🚨 Deadline extended for #PCRTokyo! You still have time to gain recognition, make an impact, and advance your career. Simply submit your Scientific Abstracts, Clinical Cases and Late-Breaking Trials by 20 October, 23:59 CET. ️➡️ Don’t miss out, submit today and be part of

🚨 Deadline extended for #PCRTokyo! You still have time to gain recognition, make an impact, and advance your career. Simply submit your Scientific Abstracts, Clinical Cases and Late-Breaking Trials by 20 October, 23:59 CET.  
 
️➡️ Don’t miss out, submit today and be part of
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

Just published on the occasion of #PCRLV: The Neo2 BAV registry evaluated the safety and efficacy of ACURATE neo2 in patients with BAV stenosis. Chiara De Biase asked first author Andreas Rück to share insights on the study⬇️

Darren Mylotte (@dmylotte) 's Twitter Profile Photo

Important paper evaluating Neo2 in Bicuspid AS. excellent results achieved in high volume centres. Good Pre and Post dil mandatory.

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

This editorial by Michael Joner & Darren Mylotte discusses new insights from van den Dorpel et al. on post-TAVI gradients: invasive >10 mmHg predicts mortality, while echo-derived values may mislead due to pressure recovery. #TAVI #CardioTwitter ow.ly/25FK50VKCVj

This editorial by <a href="/MichaelJoner3/">Michael Joner</a> &amp; <a href="/dmylotte/">Darren Mylotte</a> discusses new insights from van den Dorpel et al. on post-TAVI gradients: invasive &gt;10 mmHg predicts mortality, while echo-derived values may mislead due to pressure recovery.  #TAVI #CardioTwitter
ow.ly/25FK50VKCVj